CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Theracos

For profitContributed to NMEWebsite ↗

Also known as: Theracos | THERACOSBIO | Theracos, Inc. | Theracos Sub, LLC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Aug 1, 2007

First marketed drug

Jan 20, 2023

First NDA

Jan 20, 2023

Last known activity

Jan 20, 2023

Timeline

2000s

  1. Jan 1, 2000

    Theracos— Founded

  2. Jun 1, 2003

    Calyx Therapeutics— Acquired

2020s

  1. Jan 20, 2023

    bexagliflozin— Marketing Organization

  2. Jan 20, 2023

    bexagliflozin— NDA Organization

  3. Jan 20, 2023

    bexagliflozin— NDA Secondary Org

Drugs by trial phase (11 distinct, 21 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (29)

Details

Founded
Marlborough, MA, US Jan 1, 2000
First NDA
Jan 20, 2023
Last known activity
Jan 20, 2023